Alterations in contractile protein composition and function in human atrial dilatation and atrial fibrillation

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 3, 2006, Pages 467-477

  Eiras, S ^a   Narolska, N A ^a   van Loon, R B ^a   Boontje, N M ^a   Zaremba, R ^a   Jimenez, C R ^b   Visser, F C ^a   Stooker, W ^c   van der Velden, J ^a   Stienen, G J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Atrium; Contractility; Dilatation; Fibrillation; Protein phosphorylation; Remodeling

Indexed keywords

ACTIN; CALCIUM ION; CONTRACTILE PROTEIN; CYTOSKELETON PROTEIN; DESMIN; MYOSIN HEAVY CHAIN BETA; TROPONIN T;

ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; FORCE; HEART ATRIUM APPENDAGE; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SINUS RHYTHM; SKINNED MUSCLE FIBER; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AGED; ATRIAL FIBRILLATION; BIOPSY; CALCIUM; DENSITOMETRY; ECHOCARDIOGRAPHY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENE EXPRESSION REGULATION; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN ISOFORMS; TROPONIN T;

EID: 33748426333     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.06.072     Document Type: Article

References (37)

1. Ausma J., van der Velden H.M., Lenders M.H., van Ankeren E.P., Jongsma H.J., Ramaekers F.C., et al. Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation 107 (2003) 2051-2058
2. Ausma J., Wijffels M., Thone F., Wouters L., Allessie M., and Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96 (1997) 3157-3163
3. Schotten U., Ausma J., Stellbrink C., Sabatschus I., Vogel M., Frechen D., et al. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 103 (2001) 691-698
4. Logan W.F., Rowlands D.J., Howitt G., and Holmes A.M. Left atrial activity following cardioversion. Lancet 10 (1965) 471-473
5. Van Wagoner D.R., and Nerbonne J.M. Molecular basis of electrical remodeling in atrial fibrillation. J. Mol. Cell. Cardiol. 32 (2000) 1101-1107
6. Schotten U., Neuberger H.R., and Allessie M.A. The role of atrial dilatation in the domestication of atrial fibrillation. Prog. Biophys. Mol. Biol. 82 (2003) 151-162
7. Allessie M.A., Boyden P.A., Camm A.J., Kleber A.G., Lab M.J., Legato M.J., et al. Pathophysiology and prevention of atrial fibrillation. Circulation 103 (2001) 769-777
8. Narolska N.A., van Loon R.B., Boontje N.M., Zaremba R., Eiras Penas S., Russell J., et al. Myocardial contraction is 5-fold more economical in ventricular than in atrial human tissue. Cardiovasc. Res. 65 (2005) 221-229
9. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 (2001) 174-180
10. Narolska N.A., Eiras S., van Loon R.B., Boontje N.M., Zaremba R., Spiegelenberg S.R., et al. Myosin heavy chain composition and the economy of contraction in healthy and diseased human myocardium. J. Muscle Res. Cell. Motil. 26 (2005) 39-48
11. Herron T.J., and McDonald K.S. Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ. Res. 90 (2002) 1150-1152
12. Morano I. Tuning the human heart molecular motors by myosin light chains. J. Mol. Med. 77 (1999) 544-555
13. VanBuren P., Waller G.S., Harris D.E., Trybus K.M., Warshaw D.M., and Lowey S. The essential light chain is required for full force production by skeletal muscle myosin. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 12403-12407
14. Arrell D.K., Neverova I., Fraser H., Marban E., and Van Eyk J.E. Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1. Circ. Res. 89 (2001) 480-487
15. 2+ sensitivity of force and activation dependence of the kinetics of myocardial force development. Am. J. Physiol. 287 (2004) H2712-H2718
16. 2+-sensitivity of force is enhanced in failing human hearts. Cardiovasc. Res. 57 (2003) 505-514
17. Weyman A.E. Principles and Practice of Echocardiography. 2nd ed. (1994), Lea and Febiger, Philadelphia, PA 1289-1298 Appendix A
18. Jimenez C.R., Eyman M., Lavina Z.S., Gioio A., Li K.W., van der Schors R.C., et al. Protein synthesis in synaptosomes: a proteomics analysis. J. Neurochem. 81 (2002) 735-744
19. Baroukh N., Lopez C.E., Saleh M.C., Recalde D., Vergnes L., Ostos M.A., et al. Expression and secretion of human apolipoprotein A-I in the heart. FEBS Lett. 557 (2004) 39-44
20. van der Velden J., Moorman A.F.M., and Stienen G.J.M. Age-dependent changes in myosin composition correlate with enhanced economy of contraction in guinea-pig hearts. J. Physiol. 507 (1998) 497-510
21. T.J. Herron, M. Baghai, J.C. Kentish, Age dependence of isometric crossbridge cycling and α-MHC isoform expression in human ventricular myocytes. Biophys J 2005, Abstracts of the 49th Annual Meeting, Pos/B464.
22. Wang J., Guo X., and Dhalla N.S. Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan. Biochim. Biophys. Acta 1690 (2004) 177-184
23. Margossian S.S., White H.D., Caulfield J.B., Norton P., Taylor S., and Slayter H.S. Light chain 2 profile and activity of human ventricular myosin during dilated cardiomyopathy. Identification of a causal agent for impaired myocardial function. Circulation 85 (1992) 1720-1733
24. Morano M., Zacharzowski U., Maier M., Lange P.E., Alexi-Meskishvili V., Haase H., et al. Regulation of human heart contractility by essential myosin light chain isoforms. J. Clin. Invest. 98 (1996) 467-473
25. 2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 110 (2004) 2651-2657
26. Vest J.A., Wehrens X.H., Reiken S.R., Lehnart S.E., Dobrev D., Chandra P., et al. Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 111 (2005) 2025-2032
27. Ausma J., Litjens N., Lenders M.H., Duimel H., Mast F., Wouters L., et al. Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat. J. Mol. Cell. Cardiol. 33 (2001) 2083-2094
28. Brenner B., and Eisenberg E. Rate of force generation in muscle: correlation with actomyosin ATPase activity in solution. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 3542-3546
29. Sumandea M.P., Pyle W.G., Kobayashi T., de Tombe P.P., and Solaro R.J. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J. Biol. Chem. 278 (2003) 35135-35144
30. Krenz M., and Robbins J. Impact of beta-myosin heavy chain expression on cardiac function during stress. J. Am. Coll. Cardiol. 44 (2004) 2390-2397
31. 2+-sensitivity and ATPase activity in the mouse myocardium. J. Physiol. 552 (2003) 845-857
32. Sakthivel S., Finley N.L., Rosevear P.R., Lorenz J.N., Gulick J., Kim S., et al. In vivo and in vitro analysis of cardiac troponin I phosphorylation. J. Biol. Chem. 280 (2005) 703-714
33. Burkart E.M., Sumandea M.P., Kobayashi T., Nili M., Martin A.F., Homsher E., et al. Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J. Biol. Chem. 278 (2003) 11265-11272
34. Montgomery D.E., Chandra M., Huang Q.Q., Jin J.P., and Solaro R.J. Transgenic incorporation of skeletal TnT into cardiac myofilaments blunts PKC-mediated depression of force. Am. J. Physiol. 260 (2001) H1011-H1018
35. Noguchi T., Hunlich M., Camp P.C., Begin K.J., El-Zaru M., Patten R., et al. Thin filament-based modulation of contractile performance in human heart failure. Circulation 110 (2004) 982-987
36. Yue L., Feng J., Gaspo R., Li G.R., Wang Z., and Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ. Res. 81 (1997) 512-525
37. Lamirault G., Gaborit N., Le Meur N., Chevalier C., Lande G., Demolombe S., et al. Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man. J. Mol. Cell Cardiol. 40 (2006) 173-184